Medical/Pharmaceuticals News & Press Release Distribution

Recbio Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange

Offer Price of HK $24.80 per H Share To Raise Proceeds Up to HK$765 Million Focus on the R&D of HPV Vaccine Candidates Focus on In-house Research and Development of Novel Vaccines TAIZHOU, China, March 21, 2022 /PRNewswire/ -- The China-based novel vaccines company -Jiangsu Recbio Technology Co....

2022-03-21 14:41 5060

APA Releases Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)

WASHINGTON, March 19, 2022 /PRNewswire/ -- Today, the American Psychiatric Association (APA) released theDiagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) .The manual, which the APA has published and updated since 1952, def...

2022-03-19 02:48 4930

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates

SHANGHAI and HONG KONG, March 18, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for canc...

2022-03-18 22:12 7419

Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system

HANGZHOU, China, March 18, 2022 /PRNewswire/ -- On March 18th, 2022, Venus Medtech (Hangzhou) Inc. ("Venus Medtech", 2500.HK), a leading provider of integrated solutions for structural heart disease inChina, announced the appointment ofShakeel Osman as Senior Vice President of Sales Europe, resp...

2022-03-18 20:02 5420

Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system

I-Mab to Report Full Year 2021 Financial Results and Provide Corporate Update on March 29, 2022

SHANGHAI and GAITHERSBURG, MD, March 18, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the Company will report financial results for the ...

2022-03-18 20:00 4244

WH Group's Subsidiary Smithfield Foods Partners with BioCircuit Technologies to Deliver Innovative Nerve Repair Solution

HONG KONG, March 18, 2022 /PRNewswire/ -- WH Group Limited ("WH Group" or "the Company", HKEX stock code: 288) today announced that Smithfield BioScience, a unit of WH Group's subsidiary Smithfield Foods which delivers life-saving medical solutions from porcine-derived bioproducts, and BioCircuit...

2022-03-18 16:31 3866

WH Group's Subsidiary Smithfield Foods Partners with BioCircuit Technologies to Deliver Innovative Nerve Repair Solution

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership upon novel JAK1 inhibitor LNK01001

HANGZHOU, China, March 18, 2022 /PRNewswire/ -- On March 18, 2022, Lynk Pharmaceuticals Co., Ltd. (Lynk Pharmaceuticals) and Simcere (2096.HK) announced a strategic partnership to develop and commercialize a highly selective JAK1 inhibitor LNK01001 inChina. Under the terms of the agreement, Lynk...

2022-03-18 13:28 8975

CStone Pharmaceuticals Announces the Acceptance of New Drug Application (NDA) for Pralsetinib for the Treatment of RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) in Hong Kong, China

SUZHOU, China, March 18, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, announced today that the new drug application (...

2022-03-18 10:35 4353

ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021

Global sales continued to excel in Brazil, Turkey, Italy, and the Czech Republic in Q4 2021 CUPERTINO, Calif., March 18, 2022 /PRNewswire/ -- Zepp Health (NYSE: ZEPP), a global smart wearable and health technology leader, completed the final quarter of 2021 with yet another season of sharp and s...

2022-03-18 10:09 4496

ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021

CStone announced the global multi-regional registration trial of anti-PD-1 antibody nofazinlimab in combination with lenvatinib as first-line treatment for patients with advanced hepatocellular carcinoma successfully reached the prespecified enrollment target

SUZHOU, China, March 18, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the global multi-regional ...

2022-03-18 08:37 4544

Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy

SHANGHAI, March 18, 2022 /PRNewswire/ -- Harvest Integrated Research Organization ("HiRO" or the "Company") announced the completion of its Series A financing in the tens of millions of US dollars. This round of investment is led by OrbiMed, with the participation from existing shareholder, Fontu...

2022-03-18 08:00 6969

Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud

First of its kind initiative in India bringing wearable technology for post-surgery care. NEW DELHI and LONDON and SINGAPORE, March 18, 2022 /PRNewswire/ -- Manipal Hospitals, the second-largest healthcare services provider inIndia, today announced a strategic partnership with ConnectedLife buil...

2022-03-18 06:00 3151

China CDE Approved First Universal CAR-T IND !

NANJING, China, March 17, 2022 /PRNewswire/ -- On March 17, 2022, China National Drug Administration Drug Review Center (CDE) approved first Universal Chemeric Antigen Receptor T (UCAR-T) cell drug (Acceptance No. : CXSL2101509). CTA101 is independently developed by Nanjing Bioheng Biotech Co., L...

2022-03-17 21:32 2514

Triastek and Siemens announce strategic collaboration to accelerate digital transformation of the pharmaceutical industry

NANJING, China, March 17, 2022 /PRNewswire/ -- Triastek, Inc. and Siemens Ltd., China have signed a strategic collaboration agreement to provide digital technologies for the global pharmaceutical industry. Combining Triastek's industry-leading 3D printing and digital pharmaceutical technologies a...

2022-03-17 21:24 3310

Triastek and Siemens announce strategic collaboration to accelerate digital transformation of the pharmaceutical industry

BioVaxys Announces Bioproduction of BVX-1021 for its Pan-Sarbecovirus Program in Collaboration with The Ohio State University

VANCOUVER, BC, March 17, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it has entered into an agreement with Millipore-Sigma ("Millipore") a global Contract Development and Manufacturing Research Organization (...

2022-03-17 20:18 4724

Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary

SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today announced the appointment ofGlen Hansen, Ph.D., D(ABMM), FCCM, as the Head of Scientific and Medical Affairs of itsUnited States subs...

2022-03-17 20:00 2436

EVERSANA unveils global price and market access solution NAVLIN by EVERSANA

Next generation price and market access platform combining data, software and insights into single ecosystem CHICAGO, March 17, 2022 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today unveiledNAVLIN by EVERSANA™, a new, compr...

2022-03-17 19:10 2270

First eye drops registered on the Australian Register of Therapeutic Goods (ARTG) to slow the progression of short-sightedness now available for children aged from 4 to 14 years old[1]

SYDNEY, March 17, 2022 /PRNewswire/ -- Aspen announced the Therapeutic Goods Administration (TGA) listing of a new medication to slow the progression of short-sightedness (myopia) in children and young teenagers. EIKANCE® 0.01% eye drops (atropine sulfate monohydrate 0.01%) are available on presc...

2022-03-17 17:00 3798

KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn

MADRID, March 17, 2022 /PRNewswire/ -- KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing round which expects to achieve5 million euros to boost its projects and consolidate itself as one of the biotech sta...

2022-03-17 15:30 4096

111, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results

SHANGHAI, March 17, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the fourth qua...

2022-03-17 15:20 3142